StackTerminal.Health

Berberine

Alkaloid from Berberis plants with evidence for glycemic control and lipid improvement.

metabolic-healthlongevity
Dosing model
FLATFixed dose (no body-weight scaling).
Min dose
500 mg
Max dose
1500 mg
Rounding
250 mg

Stacks containing Berberine

Public community stacks that include this ingredient.

Explore all stacks →
dailylongevity

Foundational stack aimed at mitochondrial function, insulin sensitivity, and long-term healthspan.

Omega-3 (EPA/DHA)
2000mg
Vitamin D3
50mg
Berberine
1000mg
+ 1 more supplements
New
View
metaboliclongevityhealthspan

Targets glucose and lipid markers for long-term metabolic health.

Berberine
10000mg
Coenzyme Q10
200mg
New
View
longevity

Targets glucose and lipid markers for long-term metabolic health.

Berberine
1000mg
Coenzyme Q10
200mg
New
View
Evidence
2 records
Glycemic control in type 2 diabetes
Adults with type 2 diabetesSystematic review and meta-analysis of RCTs
Moderate

Berberine reduced fasting plasma glucose by 0.82 mmol/L, HbA1c by 0.63%, and 2-hour postprandial glucose by 1.16 mmol/L across 37 RCTs (n=3048); glucose-lowering effect correlated with baseline glucose levels.

Dose: 500–1500 mg Duration: 8–24 weeks
Dyslipidemia — LDL, triglycerides, total cholesterol
Adults with dyslipidemiaSystematic review and meta-analysis of RCTs
Moderate

Berberine reduced LDL cholesterol by 0.46 mmol/L, triglycerides by 0.34 mmol/L, and total cholesterol by 0.48 mmol/L across 18 RCTs; HDL changes differed by sex (increase in women, slight decrease in men). No serious adverse events reported.

Dose: 900–1500 mg Duration: 4–24 weeks
Forms
Berberine HCl
Most studied form.